美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Merus Labs International Inc

1.30

0.0000

成交量：- -

成交额：- -

市值：1.52亿

市盈率：-16.25

高：1.30

开：1.30

低：1.30

收：1.30

52周最高：1.33

52周最低：0.7005

股本：1.17亿

流通股本：9,731.00万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.0800

净资产收益率：--

总资产收益率：--

市净率：1.05

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Merus Labs International Inc

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.meruslabs.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Merus Labs International Inc.是根据加拿大英属哥伦比亚省法律于1973年12月注册成立，并于1997年12月根据加拿大的安大略省法律继续运营。公司是一家从事收购和许可的祖传品牌的处方药品的专业制药公司。梅鲁斯的企业发展战略是通过产品收购计划来推动的，该计划把收购良机应用在源产品收购候选产品上。这种方法允许梅鲁斯跨越广泛的治疗类到源制药产品，其可以用于不提供给其他参与者的收购目标，并建立多元化的战略采购药品。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/MSLI/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MSLI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSLI\",,,,,undefined,":{"symbol":"MSLI","market":"US","secType":"STK","nameCN":"Merus Labs International Inc","latestPrice":1.3,"timestamp":1515186000000,"preClose":1.3,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":97310000,"shares":117000000,"eps":-0.08,"marketStatus":"交易中","change":0,"latestTime":"02-26 12:36:29 EST","open":1.3,"high":1.3,"low":1.3,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.08,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772139600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.3,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSLI\",,,,,undefined,":{"symbol":"MSLI","floatShares":97310000,"roa":"--","roe":"--","lyrEps":0,"shares":117000000,"dividePrice":0,"high":1.3,"amplitude":0,"preClose":1.3,"low":1.3,"week52Low":0.7005,"pbRate":"1.05","week52High":1.3327,"institutionHeld":0,"latestPrice":1.3,"eps":-0.08,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.08,"open":1.3,"prevYearClose":1.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSLI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-05-11","symbol":"MSLI","fiscalQuarterEnding":null,"expectedEps":-0.01,"name":null,"time":"","type":"earning","dateTimestamp":1494475200000,"reportTimeType":"","actualEps":-0.01},{"market":"US","date":"2017-02-14","symbol":"MSLI","fiscalQuarterEnding":null,"expectedEps":-0.01,"name":null,"time":"盘前","type":"earning","dateTimestamp":1487048400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-12-14","symbol":"MSLI","fiscalQuarterEnding":null,"expectedEps":0,"name":null,"time":"盘前","type":"earning","dateTimestamp":1481691600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-08-15","symbol":"MSLI","fiscalQuarterEnding":null,"expectedEps":0,"name":null,"time":"盘前","type":"earning","dateTimestamp":1471233600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-05-11","symbol":"MSLI","fiscalQuarterEnding":null,"expectedEps":-0.01,"name":null,"time":"","type":"earning","dateTimestamp":1462939200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSLI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MSLI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.meruslabs.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0198},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.0165}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Merus Labs International Inc.是根据加拿大英属哥伦比亚省法律于1973年12月注册成立，并于1997年12月根据加拿大的安大略省法律继续运营。公司是一家从事收购和许可的祖传品牌的处方药品的专业制药公司。梅鲁斯的企业发展战略是通过产品收购计划来推动的，该计划把收购良机应用在源产品收购候选产品上。这种方法允许梅鲁斯跨越广泛的治疗类到源制药产品，其可以用于不提供给其他参与者的收购目标，并建立多元化的战略采购药品。","exchange":"NASDAQ","name":"Merus Labs International Inc","nameEN":"Merus Labs"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MSLI\",market:\"US\",,,undefined,":null}}